Genetic determinants of EGFR -Driven Lung Cancer Growth and Therapeutic Response In Vivo is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.243. It has been cited 3 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0352
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
National Institutes of Health
Grant: 1F32CA210516-01A1
Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Lung Adenocarcinoma
National Institutes of Health
Grant: 5R01CA234349-02
Unraveling mechanisms of tumor suppression in lung cancer
National Institutes of Health
Grant: 3P50CA196530-02S1
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
National Institutes of Health
Grant: 5R01CA231253-02
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
National Institutes of Health
Grant: 3P50CA196530-03S1
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
National Institutes of Health
Grant: 5F31CA203488-02
Modulation of the Immune System as a Strategy to Treat EGFR Mutant Lung Adenocarcinoma
National Institutes of Health
Grant: 5R01CA120247-09
Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice
Fields of Study
Keywords
Sustainable Development Goals